ATE21822T1 - Zusammensetzung aus beta-adrenorezeptorantagonisten und angstloesenden mitteln. - Google Patents

Zusammensetzung aus beta-adrenorezeptorantagonisten und angstloesenden mitteln.

Info

Publication number
ATE21822T1
ATE21822T1 AT83303641T AT83303641T ATE21822T1 AT E21822 T1 ATE21822 T1 AT E21822T1 AT 83303641 T AT83303641 T AT 83303641T AT 83303641 T AT83303641 T AT 83303641T AT E21822 T1 ATE21822 T1 AT E21822T1
Authority
AT
Austria
Prior art keywords
composition
anxiety agents
adrenoreceptor antagonists
beta adrenoreceptor
beta
Prior art date
Application number
AT83303641T
Other languages
English (en)
Inventor
Katherine Voith
Original Assignee
Ayerst Mckenna & Harrison
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayerst Mckenna & Harrison filed Critical Ayerst Mckenna & Harrison
Application granted granted Critical
Publication of ATE21822T1 publication Critical patent/ATE21822T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT83303641T 1982-06-25 1983-06-24 Zusammensetzung aus beta-adrenorezeptorantagonisten und angstloesenden mitteln. ATE21822T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/392,417 US4468391A (en) 1982-06-25 1982-06-25 Combination of β-adrenoceptor antagonists and anxiolytic agents
EP83303641A EP0098113B1 (de) 1982-06-25 1983-06-24 Zusammensetzung aus Beta-Adrenorezeptor-Antagonisten und angstlösenden Mitteln

Publications (1)

Publication Number Publication Date
ATE21822T1 true ATE21822T1 (de) 1986-09-15

Family

ID=23550497

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83303641T ATE21822T1 (de) 1982-06-25 1983-06-24 Zusammensetzung aus beta-adrenorezeptorantagonisten und angstloesenden mitteln.

Country Status (10)

Country Link
US (1) US4468391A (de)
EP (1) EP0098113B1 (de)
JP (1) JPS5916827A (de)
AT (1) ATE21822T1 (de)
AU (1) AU556173B2 (de)
CA (1) CA1200206A (de)
DE (1) DE3365860D1 (de)
GR (1) GR77542B (de)
PH (1) PH19862A (de)
ZA (1) ZA834498B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3686622T2 (de) * 1985-09-11 1993-04-01 British Tech Group Verwendung von dioxopiperidin-derivaten zur behandlung von anxietas, zur herabsetzung von chronischen abnormal hohen gehirn-spiegeln serotonins oder 5-hydroxy-indolessigsaeure und zur behandlung von bakteriellen oder viralen infektionen.
US5096586A (en) * 1990-08-28 1992-03-17 Regents Of The University Of California Membranes having selective permeability
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
JPH06190340A (ja) * 1992-09-11 1994-07-12 Sekisui Jushi Co Ltd 塗装金属体
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
CA2165802A1 (en) * 1993-09-29 1995-04-06 Eun Soo Lee Monoglyceride/lactate ester permeation enhancer for oxybutynin
US5484794A (en) * 1994-11-09 1996-01-16 Eli Lilly And Company Method for treating anxiety
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
AUPO274596A0 (en) * 1996-10-04 1996-10-31 Armstrong, Stuart Maxwell Method for the treatment of neurological or neuropsychiatric disorders
FR2834854B1 (fr) 2002-01-11 2004-05-28 Thales Sa Procede et systeme de decodage de tatouage

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1919342A1 (de) * 1969-04-16 1970-12-03 Boehringer Sohn Ingelheim Herzwirksame Kombinationspraeparate
AT303707B (de) * 1970-02-17 1972-12-11 Ciba Geigy Ag Verfahren zur Herstellung von neuen 1-sek.Amino-2-hydroxy-3-[(p-alkenyloxy- oder p-alkinyloxy)-phenoxy]-propanen und ihren Säureadditionssalzen
DE2106071A1 (de) * 1970-02-17 1971-10-07 CIBA Geigy AG, Basel (Schweiz) Neue pharmazeutische Präparate
US3959486A (en) * 1970-05-27 1976-05-25 Imperial Chemical Industries Limited Method for producing β-adrenergic blockage with alkanolamine derivatives
US4059622A (en) * 1970-05-27 1977-11-22 Imperial Chemical Industries Limited Alkanolamine derivatives
LU76150A1 (de) * 1976-11-08 1978-07-10
DE2752384A1 (de) * 1977-08-29 1979-03-15 Simes Pharmazeutisches praeparat auf der basis beklemmungsloesender mittel und hemmstoffe der beta-adrenergischen rezeptoren
DE2926653A1 (de) * 1979-07-02 1981-01-22 Sandoz Ag Neue therapeutische verwendung von organischen verbindungen

Also Published As

Publication number Publication date
CA1200206A (en) 1986-02-04
US4468391A (en) 1984-08-28
EP0098113B1 (de) 1986-09-03
AU1599283A (en) 1984-01-05
JPS5916827A (ja) 1984-01-28
GR77542B (de) 1984-09-24
EP0098113A1 (de) 1984-01-11
ZA834498B (en) 1985-02-27
DE3365860D1 (en) 1986-10-09
PH19862A (en) 1986-08-13
AU556173B2 (en) 1986-10-23

Similar Documents

Publication Publication Date Title
ATE21822T1 (de) Zusammensetzung aus beta-adrenorezeptorantagonisten und angstloesenden mitteln.
AR002705A1 (es) Un nuevo compuesto de indolina, un proceso para su preparacion y composiciones farmaceuticas que lo contienen.
ATE15798T1 (de) Heterozyklische carboxamide, zubereitungen, die solche verbindungen enthalten, verfahren zu ihrer herstellung und methoden zur behandlung damit.
MX9401191A (es) Compuestos del grupo sulfamoilo y amidino, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
HU9203383D0 (en) 2-amino-methyl-chromane derivatives and method for producing said compounds and pharmaceutical preparatives containing them
MA19951A1 (fr) Procede de preparation d'acides amines tricycliques ainsi que des acides amines bicycliques servant d'intermediaires et leur utilisation comme medicament
MX9305294A (es) Compuestos de decahidroisoquinolina, procedimiento para su preparacion y formulacion farmaceutica que los comprende.
MX9203775A (es) Compuestos arilicos biciclicos substituidos, que exhiben actividad antagonista al leucotrieno b4 selectiva.
DE69224448T2 (de) Imidazol-Verbindungen, Verfahren zu ihrer Herstellung und ihre Anwendung
ATE158183T1 (de) Arzneimittel zur behandlung von anxietas
ES2161718T3 (es) 2,5-dioxo-2,5-dihidro-1h-benzo(b)azepinas como antagonistas de los receptores de nmda.
AR229703A1 (es) Procedimiento para la preparacion de nuevos 2-guanidino-4-heteroariltiazoles activos como agentes antisecretores y como antagonistas h2 de la histamina
ATE11134T1 (de) 1-(3-halogen-2-pyridinyl)piperazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
FI811672L (fi) Nya substituerade 3-fenoxi-1-alkoxi-karbonyl-alkylamino-propanol-2-foereningar med beta-receptor haemmande verkan
PT77238B (de) Substituierte tert.-butanol-derivate verfahren zu ihrer herstellung und diese enthaltende antimykotische mittel
DK229984A (da) 4-oxothiazolidin-2-yliden-acetamidderivater
JPS57136518A (en) Immunoregulator
ES2095984T3 (es) 2,3-dihidropirano(2,3-b)piridinas aminometil sustituidas, procedimiento para su preparacion y su uso en medicamentos.
ATE167628T1 (de) Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion
ATE37871T1 (de) Substituierte azabicycloalkane, ihre verwendung, pharmazeutische praeparate, welche diese verbindungen enthalten, und verfahren zur herstellung dieser verbindungen.
AR010304A1 (es) Compuestos de dimesilato de cis-1-(3-etoxifenil)-1-4-fenilpiperazin-1-il) -4-metilciclohexano; procedimiento para su preparacion y composicionfarmaceutica
GB1126353A (en) Isoquinolinobenzodiazepine derivatives
ES541944A0 (es) Procedimiento para preparar liposomas que contiene alergenoso fracciones de alergenos inhalables
IT8420061A0 (it) Procedimento per la decontaminazione esauriente degli olii perfluoropolieteri.
ATE80998T1 (de) Verwendung von nalmefen zur herstellung eines arzneimittels zur behandlung der schaedigung des zentralnervensystems.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee